No Data
No Data
Express News | HOOKIPA Pharma Inc : Leerink Partners Adjusts Target Price to $15 From $4 to Reflect 1-for-10 Reverse Stock Split
HOOKIPA Pharma Appoints Malte Peters CEO, Terry Coelho CFO
HOOKIPA Pharma: Review Process Will Not Impact Ops or Clinical Trials >HOOK
HOOKIPA Pharma: Jörn Aldag, Reinhard Kandera Will Be Leaving Co and Stepping Down From Board
Express News | HOOKIPA Pharma : Sean Cassidy Appointed to Board of Directors
HOOKIPA Pharma Conducting Review of Business Ops and Strategy to Determine Best Path to Create Shareholder Value